A New Drug Rewrites Obesity Treatment, but Not the Bill
With Estonia ranking as Europe's fifth fattest nation, the demand for GLP-1 medications has doubled in two years, outpacing state policy. New 'triple-agonist' d…
Elisabeth Saar
·
Sep 30, 2026 • 08:44
